Suppr超能文献

肝素结合细胞因子及基于肝素类似物的细胞载体

Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers.

机构信息

Division of Biomedical Engineering, Research Institute, National Defense Medical College, 3-2 Namiki, Tokorazawa, Saitama 359-8513, Japan.

Department of Oral and Maxillofacial Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan.

出版信息

Molecules. 2019 Dec 17;24(24):4630. doi: 10.3390/molecules24244630.

Abstract

Heparinoid is the generic term that is used for heparin, heparan sulfate (HS), and heparin-like molecules of animal or plant origin and synthetic derivatives of sulfated polysaccharides. Various biological activities of heparin/HS are attributed to their specific interaction and regulation with various heparin-binding cytokines, antithrombin (AT), and extracellular matrix (ECM) biomolecules. Specific domains with distinct saccharide sequences in heparin/HS mediate these interactions are mediated and require different highly sulfated saccharide sequences with different combinations of sulfated groups. Multivalent and cluster effects of the specific sulfated sequences in heparinoids are also important factors that control their interactions and biological activities. This review provides an overview of heparinoid-based biomaterials that offer novel means of engineering of various heparin-binding cytokine-delivery systems for biomedical applications and it focuses on our original studies on non-anticoagulant heparin-carrying polystyrene (NAC-HCPS) and polyelectrolyte complex-nano/microparticles (N/MPs), in addition to heparin-coating devices.

摘要

肝素类似物是一个通用术语,用于指肝素、硫酸乙酰肝素 (HS) 和动物或植物来源的肝素样分子以及硫酸化多糖的合成衍生物。肝素/HS 的各种生物学活性归因于它们与各种肝素结合细胞因子、抗凝血酶 (AT) 和细胞外基质 (ECM) 生物分子的特异性相互作用和调节。肝素/HS 中具有特定糖序列的特定结构域介导这些相互作用,并需要不同组合的高度硫酸化糖序列和不同的硫酸基团。肝素类似物中特定硫酸化序列的多价和簇效也是控制其相互作用和生物学活性的重要因素。本综述提供了基于肝素类似物的生物材料的概述,这些材料为各种肝素结合细胞因子递药系统的工程提供了新的手段,用于生物医学应用,除了肝素涂层装置外,本文还重点介绍了我们关于非抗凝肝素载聚苯乙烯 (NAC-HCPS) 和聚电解质复合物纳米/微米颗粒 (N/MPs) 的原创研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/928d/6943580/e8bbb5e50658/molecules-24-04630-g001.jpg

相似文献

1
Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers.
Molecules. 2019 Dec 17;24(24):4630. doi: 10.3390/molecules24244630.
2
Heparinoids Danaparoid and Sulodexide as clinically used drugs.
Prog Mol Biol Transl Sci. 2019;163:55-74. doi: 10.1016/bs.pmbts.2019.02.005. Epub 2019 Mar 21.
3
Structure and biological activity of heparinoid.
Mini Rev Med Chem. 2005 May;5(5):441-7. doi: 10.2174/1389557053765538.
4
Design of biologically active heparan sulfate and heparin using an enzyme-based approach.
Nat Prod Rep. 2009 May;26(5):610-27. doi: 10.1039/b803795g. Epub 2009 Feb 27.
5
Anticoagulant and antiprotease activities of a heparinoid sulfated glucoside-bearing polymer.
J Biomater Sci Polym Ed. 1998;9(9):973-84. doi: 10.1163/156856298x00280.
6
Heparin-protein interactions.
Angew Chem Int Ed Engl. 2002 Feb 1;41(3):391-412. doi: 10.1002/1521-3773(20020201)41:3<390::aid-anie390>3.0.co;2-b.
7
Direct observation of fibrinogen-heparinoid complexes formation using surface plasmon resonance.
Bioconjug Chem. 1999 May-Jun;10(3):538-43. doi: 10.1021/bc970218j.
8
Characterization of anticoagulant heparinoids by immunoprofiling.
Glycoconj J. 2008 Feb;25(2):177-85. doi: 10.1007/s10719-007-9070-z. Epub 2007 Oct 2.
9
Heparin based polyurethanes: A state-of-the-art review.
Int J Biol Macromol. 2016 Mar;84:101-11. doi: 10.1016/j.ijbiomac.2015.12.004. Epub 2015 Dec 5.
10
Heparinoid anticoagulation and topical fibrin sealant in heparin-induced thrombocytopenia.
Ann Thorac Surg. 1997 Dec;64(6):1815-7. doi: 10.1016/s0003-4975(97)01065-5.

本文引用的文献

1
Comparison of the Interactions of Different Growth Factors and Glycosaminoglycans.
Molecules. 2019 Sep 16;24(18):3360. doi: 10.3390/molecules24183360.
2
Protein interactome analysis of iduronic acid-containing glycosaminoglycans reveals a novel flagellar invasion factor MbhA.
J Proteomics. 2019 Sep 30;208:103485. doi: 10.1016/j.jprot.2019.103485. Epub 2019 Aug 14.
3
Polyelectrolyte Complexes of Natural Polymers and Their Biomedical Applications.
Polymers (Basel). 2019 Apr 12;11(4):672. doi: 10.3390/polym11040672.
4
Chitosan-Based Nanomaterials for Drug Delivery.
Molecules. 2018 Oct 16;23(10):2661. doi: 10.3390/molecules23102661.
5
The effect of interleukin-8 truncations on its interactions with glycosaminoglycans.
Biopolymers. 2018 Aug;109(10):e23103. doi: 10.1002/bip.23103. Epub 2018 Jan 27.
7
Modulation of binding to vascular endothelial growth factor and receptor by heparin derived oligosaccharide.
Carbohydr Polym. 2017 Oct 15;174:558-564. doi: 10.1016/j.carbpol.2017.06.127. Epub 2017 Jul 3.
8
Modulation of Interleukin-12 activity in the presence of heparin.
Sci Rep. 2017 Jul 13;7(1):5360. doi: 10.1038/s41598-017-05382-1.
9
Heparin, Heparan Sulphate and the TGF-β Cytokine Superfamily.
Molecules. 2017 Apr 29;22(5):713. doi: 10.3390/molecules22050713.
10
Heparin coatings for improving blood compatibility of medical devices.
Adv Drug Deliv Rev. 2017 Mar;112:12-23. doi: 10.1016/j.addr.2016.12.002. Epub 2016 Dec 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验